Cresco Labs Inc (CRLBF)
2.055
+0.06
(+2.75%)
USD |
OTCM |
May 08, 15:59
Cresco Labs Gross Profit Margin (Quarterly): 51.08% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 51.08% |
| September 30, 2023 | 49.14% |
| June 30, 2023 | 43.81% |
| March 31, 2023 | 44.22% |
| December 31, 2022 | 43.94% |
| September 30, 2022 | 47.09% |
| June 30, 2022 | 51.70% |
| March 31, 2022 | 50.08% |
| December 31, 2021 | 50.52% |
| September 30, 2021 | 50.27% |
| Date | Value |
|---|---|
| June 30, 2021 | 48.09% |
| March 31, 2021 | 48.77% |
| December 31, 2020 | 45.89% |
| September 30, 2020 | 50.13% |
| June 30, 2020 | 33.72% |
| March 31, 2020 | 35.53% |
| December 31, 2019 | 18.49% |
| September 30, 2019 | 57.56% |
| June 30, 2019 | 83.44% |
| March 31, 2019 | 50.59% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
18.49%
Minimum
Dec 2019
83.44%
Maximum
Jun 2019
47.55%
Average
48.77%
Median
Mar 2021
Gross Profit Margin (Quarterly) Benchmarks
| Flora Growth Corp | 19.42% |
| Tilray Brands Inc | 26.23% |
| Clever Leaves Holdings Inc | -7.46% |
| Seelos Therapeutics Inc | -- |
| Skye Bioscience Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -34.34% |
| Return on Assets | -11.85% |
| Return on Invested Capital | -17.35% |
| Profit Margin (Quarterly) | 1.40% |
| Operating Margin (Quarterly) | 14.38% |
| Return on Net Operating Assets | -12.92% |